De-escalation in breast cancer surgery

In recent years, several trials of breast cancer treatment have failed to demonstrate a survival benefit for some previously routine surgical therapies in selected patient groups. As each of these therapeutic approaches has been deemed of low value deimplementation has varied significantly. This dem...

Descripción completa

Detalles Bibliográficos
Autores principales: Shubeck, Sarah P., Morrow, Monica, Dossett, Lesly A.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2022
Materias:
Comment
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8866473/
https://www.ncbi.nlm.nih.gov/pubmed/35197478
http://dx.doi.org/10.1038/s41523-022-00383-4
Descripción
Sumario:In recent years, several trials of breast cancer treatment have failed to demonstrate a survival benefit for some previously routine surgical therapies in selected patient groups. As each of these therapeutic approaches has been deemed of low value deimplementation has varied significantly. This demonstrates that effective de-escalation in breast cancer surgery relies on more than the availability of data from randomized controlled trials and other high-quality evidence, but is also influenced by various stakeholders, social expectations, and environmental contexts.

Ejemplares similares